The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.

CHAI was founded in 2002 in response to the HIV/AIDS epidemic with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.

At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skillsets and life experiences. CHAI is deeply grounded in the countries we work in, with majority of our staff based in program countries. Learn more about our exciting work: http://www.clintonhealthaccess.org

CHAI is an Equal Opportunity Employer, and is committed to providing an environment of fairness, and mutual respect where all applicants have access to equal employment opportunities. CHAI values diversity and inclusion, and recognizes that our mission is best advanced by the leadership and contributions of people with diverse experience, backgrounds, and culture.

Talent is the fundamental driver of CHAI’s success in helping save lives and reduce the burden of disease. CHAI’s organizational values reflect its relentless endeavour of hiring, nurturing, empowering, and celebrating diverse and high-calibre individuals who come together to work as cohesive teams. CHAI places a high premium on providing its staff with an enabling environment that encourages entrepreneurship, humility, respect, equal share of voice and fosters high-impact innovation to address some of the most challenging healthcare issues.

Global Markets Team Overview:

CHAI’s Global Markets Team (GMT) strives to build healthier marketplaces for vital medical commodities in LMICs. In particular, GMT is responsible for envisioning, executing, and monitoring market-shaping interventions aimed at improving the efficiency of health commodity markets for LMICs. These interventions range from traditional policy-led and grant-financed initiatives such as pooled procurement, coordinated ordering, strategic demand forecasting, and regulatory harmonization, to more innovative credit enhancement mechanisms such as volume guarantees (VGs), procurement guarantees, development incentive grants, and working capital facilities.

See some examples of GMT’s work below:

• CHAI announces agreements with leading generic manufacturers to make affordable COVID-19 treatment available in low- and middle-income countries
• Breakthrough agreement will reduce costs and increase access to diagnostic technology for millions in low- and middle-income countries
• Breakthrough global agreement sharply lowers price of early infant diagnosis of HIV
• Landmark HIV Diagnostic Access Program Will Save US$150M

To conduct its work, the GMT closely collaborates with stakeholders on both the supply and demand sides of the market as well as at both the country and global levels. The GMT plays a leading role within CHAI in terms of managing relationships with major pharmaceutical and diagnostics companies to shape their access programs. The GMT also leads CHAI’s engagement with generic firms, assisting in the development of licensing agreements, product development agreements, and entry of generic products into new markets.

Within the GMT, the infectious disease team is responsible for envisioning, executing, and monitoring market shaping interventions aimed at improving the efficiency of health commodity markets for lower-income countries across infectious diseases portfolios such as HIV, TB, HCV etc.

Senior Analyst Role Overview:

The Senior Analyst will conduct market research on harm reduction products and support the development of a market-shaping strategy for key harm reduction commodities including recommendations on last-mile systems strengthening for key harm-reduction commodities. Their primary responsibility will be to gather market intelligence, prepare analyses for the development and implementation of CHAI’s global supply-side strategy for the key harm reduction commodities, support supplier engagement, and collaborate with a range of internal and external stakeholders to design and implement interventions to ensure sufficient supply of affordable and high-quality harm reduction commodities to low and middle-income markets. The position may require travel for supplier and partner meetings as well as to CHAI program countries.

We are seeking a highly motivated, entrepreneurial individual with outstanding problem-solving ability and communication skills. The Senior Analyst must be able to function independently and have a strong commitment to excellence. CHAI places great value on relevant personal qualities: resourcefulness, humility, responsibility, tenacity, independence, and work ethic.

To Note: This position is intended to be based in a CHAI Program Country in South East Asia pending country leadership approval.

• Conduct market research on harm reduction products
• Develop a detailed understanding and documentation of supplier dynamics, including market share of suppliers, pricing offered by suppliers, timelines for product development and manufacturing, timelines for obtaining quality assurance for harm reduction commodities, status of in-country registration of drugs, in-country dossier filing timelines, and suppliers’ development and access strategies
• Analyze market trends and develop demand forecasts and uptake models for harm reduction commodities and services
• Support the Global Market Team (GMT) in evaluating the potential for various market-shaping interventions for key harm reduction commodities including last-mile systems strengthening for key harm-reduction commodities
• Liaise with the R&D team, the disease team and country teams to develop the market analysis required to support negotiations with suppliers to expedite time-to-market, reduce pricing and improve supply security
• Contribute to the development and evaluation of Request of Proposals for commodities and services in collaboration with CHAI country programs and government partners
• Prepare presentations, reports, and other analyses to inform GMT’s market shaping strategy. Present findings of analyses to internal and or external audiences
• Any other activities as required by the Manager and Director, Global Markets
• Travel within India, Europe, and CHAI program countries,

• Bachelor’s or Master’s degree in Economics, Public Health, Business, or a related field
• Relevant work experience of 3 years in results-oriented environments in the public sector and/or private
• Proficiency in understanding data, making insights from data, and advanced level of presentation of complex data in a simplified manner.
• Excellent analytical (qualitative and quantitative) skills and strong written and oral communication skills including development of analyses/ presentations for varied project audience/stakeholders
• Entrepreneurial mindset: demonstrated ability to operate in an unstructured but demanding multicultural environment independently
• Demonstrated ability to multi-task, set priorities, and rapidly absorb/synthesize a broad range of information
• Exceptional diplomatic and interpersonal skills, and ability to build strong professional relationships with a range of stakeholders in a challenging, multi-cultural environment
• Ability to collaborate remotely with team members spread across geographies
• High level of proficiency in Microsoft Office, particularly Excel, PowerPoint and Word
• English language fluency, both written and verbal
• Willingness to travel frequently and at short notice

Skills and Traits

• Strong problem-solving ability
• Stakeholder management
• Drafting proposals and collaborative documents
• Should be able to multitask with multiple stakeholders keeping CHAI ideals and goals in mind
• Effective and prompt communication
• Ability to respond to critical situations in an effective and efficient manner

Preferred

• Candidates with experience in management consulting, investment banking, and/or the pharmaceutical or medical technology industry
• Experience living and working in a low-resourced setting
• Willingness to travel as and when required